Background: The aim of this pilot study was to determine whether measuring
sputum differential cell counts, particularly eosinophils, could be a usefu
l method of validating self-reported symptoms suggesting asthma in epidemio
logic studies.
Materials and methods: In this cross-sectional study, we selected four grou
ps of adult subjects by reported symptoms and diagnoses from among those pr
eviously randomly identified in a population study. Subjects were selected
with no respiratory symptoms ever (normal group), or reporting a diagnosis
of asthma (asthma group), or reporting recurrent wheezing not diagnosed as
asthma (wheeze group), or reporting exposure to industrial irritants, but n
ot asthma or wheezing (exposed group). Current respiratory symptoms, airway
responsiveness to methacholine challenge, and sputum cell counts were dete
rmined. The study was completed by 107 subjects aged 20 to 44 years.
Results: There were no significant differences in FEV1 percent predicted, t
otal cell count, and sputum eosinophil count among the four groups. Subject
s with reported asthma had greater airway responsiveness as reflected in a
lower bronchial reactivity (BR) index. There was a weak correlation between
BR index and sputum eosinophils.
Conclusion: In a community setting, induced sputum eosinophil cell counts i
n subjects reporting asthma or wheezing were most often within the normal r
ange and not sufficiently often abnormal to be useful in validating a diagn
osis of asthma in epidemiologic studies.